iifl-logo

Entero Healthcare Solutions Ltd Board Meeting

1,154.65
(1.55%)
Apr 1, 2025|12:00:00 AM

Entero Healthcar CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting21 Mar 202521 Mar 2025
Outcome of Board Meeting held on March 21, 2025
Board Meeting12 Feb 20253 Feb 2025
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve and take on record the standalone and consolidated unaudited financial results of the Company for the Quarter and Nine-months ended December 31 2024. Submission of Unaudited Financial Results for the quarter and nine months ended December 31, 2024 Outcome of Board Meeting held on February 12, 2025 (As Per BSE Announcement Dated on 12/02/2025)
Board Meeting16 Jan 202516 Jan 2025
Intimation for appointment of Mrs. Sanu Vishal Kapoor as Company Secretary and Compliance Officer of the Company. Allotment of equity shares against the exercise of ESOPs
Board Meeting12 Nov 20246 Nov 2024
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting held on November 12, 2024 (As Per Bse Announcement Dated on 12.11.2024)
Board Meeting14 Aug 20248 Aug 2024
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended June 30 2024 Outcome of Board Meeting held on August 14, 2024 (As per BSE Announcement Dated on 14/08/2024)
Board Meeting2 Aug 20242 Aug 2024
Submission of outcome of Board Meeting held on August 02, 2024
Board Meeting28 Jun 202428 Jun 2024
Outcome of Board Meeting held on June 28, 2024 Entero Healthcare Solutions Limited (Entero) has informed the Exchange about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held on June 28, 2024.
Board Meeting29 May 202422 May 2024
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31 2024 Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2024 Outcome of Board Meeting held on May 29, 2024 (As Per BSE Announcement Dated on 29.05.2024) Revised outcome due type error in Annexure E (As Per BSE Announcement Dated on 30.05.2024)
Board Meeting6 May 20246 May 2024
The Board of Directors of Entero Healthcare Solutions Limited (Company) has approved, inter-alia, to execute the definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held today i.e. 6th May 2024. The Board of Directors of Entero Healthcare Solutions Limited (Company) has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024.

Entero Healthcar: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.